First Mercantile Trust Co. increased its stake in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 64.5% during the first quarter, HoldingsChannel reports. The institutional investor owned 995 shares of the company’s stock after buying an additional 390 shares during the quarter. First Mercantile Trust Co.’s holdings in Tabula Rasa HealthCare were worth $56,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of TRHC. Quantamental Technologies LLC acquired a new stake in Tabula Rasa HealthCare during the fourth quarter worth approximately $64,000. Oppenheimer Asset Management Inc. acquired a new stake in Tabula Rasa HealthCare during the fourth quarter worth approximately $135,000. South Dakota Investment Council acquired a new stake in Tabula Rasa HealthCare during the first quarter worth approximately $141,000. LS Investment Advisors LLC grew its position in Tabula Rasa HealthCare by 11.2% during the first quarter. LS Investment Advisors LLC now owns 3,129 shares of the company’s stock worth $177,000 after buying an additional 316 shares in the last quarter. Finally, RMB Capital Management LLC bought a new stake in Tabula Rasa HealthCare during the fourth quarter worth $220,000. 82.79% of the stock is currently owned by institutional investors and hedge funds.

In other news, President Orsula V. Knowlton sold 8,000 shares of the stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $57.02, for a total value of $456,160.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Calvin H. Knowlton sold 8,270 shares of the stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $53.68, for a total value of $443,933.60. The disclosure for this sale can be found here. Insiders sold a total of 48,270 shares of company stock valued at $2,565,774 over the last quarter. 14.00% of the stock is owned by corporate insiders.

Several equities research analysts have weighed in on the company. BidaskClub cut Tabula Rasa HealthCare from a “sell” rating to a “strong sell” rating in a research note on Saturday, February 9th. Cantor Fitzgerald restated a “buy” rating and set a $99.00 target price on shares of Tabula Rasa HealthCare in a research note on Monday, May 13th. ValuEngine cut Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research note on Monday, May 13th. Oppenheimer cut their target price on Tabula Rasa HealthCare from $97.00 to $88.00 and set an “outperform” rating for the company in a research note on Wednesday, March 6th. Finally, Zacks Investment Research cut Tabula Rasa HealthCare from a “hold” rating to a “sell” rating in a research note on Wednesday, May 15th. Five analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. Tabula Rasa HealthCare currently has an average rating of “Buy” and an average price target of $82.12.

NASDAQ TRHC opened at $42.83 on Friday. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.80 and a quick ratio of 1.73. Tabula Rasa HealthCare Inc has a fifty-two week low of $42.29 and a fifty-two week high of $91.16. The firm has a market cap of $941.75 million, a price-to-earnings ratio of 125.97 and a beta of 1.51.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings results on Wednesday, May 8th. The company reported ($0.14) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.14). Tabula Rasa HealthCare had a positive return on equity of 4.22% and a negative net margin of 18.15%. The company had revenue of $60.96 million during the quarter, compared to analysts’ expectations of $59.24 million. As a group, analysts predict that Tabula Rasa HealthCare Inc will post -0.55 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://theolympiareport.com/2019/05/24/first-mercantile-trust-co-has-56000-position-in-tabula-rasa-healthcare-inc-trhc.html.

Tabula Rasa HealthCare Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.

Featured Article: What is the Consumer Price Index (CPI)?

Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.